Near Infrared Technology & Laparoscopic Resection of Pancreatic Lesions:

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether the use of Near-Infrared Technology can guide the laparoscopic resection of hypervascular neoplasms of the pancreas.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Carcinoid Tumor
Carcinoma, Renal Cell
Clear Cell Renal Carcinoma
Kidney Neoplasms
Neuroendocrine Tumors
Pancreatic Neoplasms
Pancreatic Neuroendocrine Tumors
Solid Pseudopapillary Tumors of the Pancreas

Clinical Trial Details

NCT number	NCT02685553
Study type	Interventional
Source	Universita di Verona
Contact
Status	Completed
Phase	Phase 1
Start date	February 2016
Completion date	October 2016

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT03053999` - Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
	Completed	`NCT02586844` - Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors
	Terminated	`NCT00947167` - A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors	Phase 2
	Completed	`NCT02842749` - Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China	Phase 4
	Completed	`NCT01384617` - Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy	N/A
	Unknown status	`NCT01381822` - Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors	Phase 1
	Completed	`NCT02841865` - Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria
	Completed	`NCT01121562` - Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors	Phase 2
	Completed	`NCT02282059` - The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors
	Terminated	`NCT01648465` - Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors	Phase 2
	Terminated	`NCT02110563` - Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma	Phase 1
	Completed	`NCT02125929` - Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms	N/A